CHEPLAPHARM Adopts TraceLink MINT to Digitalize Global Supply Chain
CHEPLAPHARM is implementing the Multienterprise Information Network Tower (MINT) from TraceLink to unify and digitalize its global supply chain operations, announced in a press release. The German pharmaceutical company will use MINT, powered by the Orchestration Platform for Universal Solutions (OPUS), to automate key workflows and improve data exchange with its international partners.
The MINT platform will allow CHEPLAPHARM to exchange operational data such as purchase orders, delivery updates, and shipment notifications directly between enterprise systems. This move replaces manual processes that relied on emails and spreadsheets, aiming to reduce administrative workloads and increase transparency across its network.
CHEPLAPHARM selected TraceLink for its Integrate-Once model, which enables rapid partner onboarding through a single network connection without additional cost to partners. The system standardizes data exchange between CHEPLAPHARM’s SAP environment and the diverse ERP systems used by its global suppliers, minimizing customization and reducing IT complexity.
The company expects the implementation to strengthen operational resilience and provide a foundation for future use of agent-based intelligence within supply chain management.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 McGraw Hill Adds AI Study Tools to Connect Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 ALTOUR Unveils AI Platform for Corporate Travel Decisions Oct 16 BOC Group Adds AI Assistant to ADOIT 21More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Phaidra to Deploy Prism Across Aligned Data Centers Portfolio
IPC Global Reaches Select Tier in Claude Partner Network
HCLTech and Anthropic Partner on Enterprise Claude Deployments
Lippert Selects ketteQ for AI Supply Chain Planning
Integrity Brings AI Insurance Tools to Mint Health
Daily AI Brief: the AI news that matters, in your inbox.